Cytek Biosciences, Inc. financial data

Symbol
CTKB on Nasdaq
Location
Fremont, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 05 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 545% % -20%
Quick Ratio 67% % -28%
Debt-to-equity 29% % 11%
Operating Margin -12% % 91%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 127,864,830 shares -0.73%
Common Stock, Shares, Outstanding 127,864,830 shares -1.5%
Entity Public Float $670,000,000 USD -35%
Common Stock, Value, Issued $128,000 USD -1.5%
Weighted Average Number of Shares Outstanding, Basic 127,547,859 shares -2.6%
Weighted Average Number of Shares Outstanding, Diluted 127,547,859 shares -3.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $201,211,000 USD 813%
Revenue from Contract with Customer, Excluding Assessed Tax $196,828,000 USD -2.2%
Research and Development Expense $37,230,000 USD -8.2%
Selling and Marketing Expense $48,183,000 USD -1.3%
General and Administrative Expense $51,619,000 USD 15%
Operating Income (Loss) $31,805,000 USD -35%
Nonoperating Income (Expense) $16,317,000 USD 39%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $15,488,000 USD -30%
Income Tax Expense (Benefit) $2,667,000 USD -52%
Net Income (Loss) Attributable to Parent $11,402,000 USD -85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $93,281,000 USD -43%
Accounts Receivable, after Allowance for Credit Loss, Current $56,632,000 USD 7.6%
Inventory, Net $51,649,000 USD 10%
Other Assets, Current $2,917,000 USD 25%
Assets, Current $388,489,000 USD -0.44%
Property, Plant and Equipment, Net $18,046,000 USD -2.5%
Operating Lease, Right-of-Use Asset $11,158,000 USD 10%
Intangible Assets, Net (Excluding Goodwill) $17,676,000 USD -14%
Goodwill $16,698,000 USD 3.2%
Other Assets, Noncurrent $4,459,000 USD -9.9%
Assets $494,919,000 USD 0.75%
Accrued Liabilities, Current $20,233,000 USD -2.4%
Contract with Customer, Liability, Current $28,739,000 USD -28%
Liabilities, Current $75,207,000 USD 20%
Contract with Customer, Liability, Noncurrent $16,315,000 USD
Operating Lease, Liability, Noncurrent $13,494,000 USD 74%
Other Liabilities, Noncurrent $2,519,000 USD 19%
Liabilities $116,348,000 USD 10%
Accumulated Other Comprehensive Income (Loss), Net of Tax $821,000 USD 713%
Retained Earnings (Accumulated Deficit) $57,662,000 USD -29%
Stockholders' Equity Attributable to Parent $378,571,000 USD -1.8%
Liabilities and Equity $494,919,000 USD 0.75%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $125,000 USD -103%
Net Cash Provided by (Used in) Financing Activities $11,545,000 USD -816%
Net Cash Provided by (Used in) Investing Activities $9,452,000 USD
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 127,864,830 shares -1.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,446,000 USD -328%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $93,281,000 USD -43%
Deferred Tax Assets, Valuation Allowance $2,800,000 USD 23%
Deferred Tax Assets, Gross $38,754,000 USD 7.7%
Operating Lease, Liability $16,586,000 USD 47%
Depreciation $3,800,000 USD 12%
Payments to Acquire Property, Plant, and Equipment $849,000 USD 50%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $12,103,000 USD -43%
Lessee, Operating Lease, Liability, to be Paid $20,950,000 USD 78%
Property, Plant and Equipment, Gross $29,654,000 USD 12%
Operating Lease, Liability, Current $3,092,000 USD -12%
Lessee, Operating Lease, Liability, to be Paid, Year Two $3,634,000 USD 45%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,366,000 USD -8%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 32%
Deferred Income Tax Expense (Benefit) $336,000 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,364,000 USD 771%
Lessee, Operating Lease, Liability, to be Paid, Year Three $3,200,000 USD 38%
Deferred Tax Assets, Operating Loss Carryforwards $1,610,000 USD 14%
Unrecognized Tax Benefits $3,599,000 USD -0.99%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,535,000 USD -25%
Additional Paid in Capital $435,284,000 USD 1.2%
Amortization of Intangible Assets $3,700,000 USD 5.7%
Depreciation, Depletion and Amortization $1,875,000 USD 10%
Deferred Tax Assets, Net of Valuation Allowance $35,954,000 USD 6.7%
Share-based Payment Arrangement, Expense $26,062,000 USD 2.1%
Interest Expense $1,839,000 USD -31%